Thu, Nov 05, 2026 - Page 73
18132 indexed SquawkNews stories from this UTC day. Showing 8641-8760.
M
GPGI Sees 2026 Adjusted EBITDA of $520M-$550M
EARNINGS | Nov 05, 2026, 12:06 PM UTC
M
Asian Tech Stocks Tumble in Tokyo and Seoul; Hong Kong Surges
South Korea’s KOSPI fell 5.3%, while Japan’s Nikkei 225 also declined. Hong Kong shares rose.
EQUITY | Nov 05, 2026, 12:06 PM UTC
M
Lexicon Pharmaceuticals Reports Q3 2026 Revenue of $11.3 Million
Lexicon reported a net loss of $14.0 million, or $0.03 per share, and ended September with $183.2 million in cash and investments. Revenue was $11.3 million, compared with $14.2 million a year earlier.
EQUITY | Nov 05, 2026, 12:06 PM UTC
L
CareCloud Reports Third-Quarter EPS
EARNINGS | Nov 05, 2026, 12:06 PM UTC
M
Frontdoor Reports Third-Quarter 2026 Results
Revenue increased 6% to $655 million, and net income increased 10% to $116 million.
EQUITY | Nov 05, 2026, 12:06 PM UTC
L
Korro Bio Reports 3Q R&D Expenses of $12.1M
EQUITY | Nov 05, 2026, 12:06 PM UTC
M
BoE to monitor second-round inflation effects and rate restrictiveness
The MPC says it will continue monitoring second-round inflation effects and whether Bank Rate is sufficiently restrictive.
CENTRAL_BANK | Nov 05, 2026, 12:06 PM UTC
M
BoE Says Inflation Pressure Risk Has Increased Since September
CENTRAL_BANK | Nov 05, 2026, 12:06 PM UTC
M
BOE says most MPC members see economic slack and restrictive policy
CENTRAL_BANK | Nov 05, 2026, 12:06 PM UTC
M
CareCloud reports third-quarter revenue of $33.7 million
EQUITY | Nov 05, 2026, 12:06 PM UTC
L
Borussia Dortmund reports preliminary figures for the first quarter (Q1) of the 2026/2027 financial year
Borussia Dortmund GmbH & Co. Kommanditgesellschaft auf Aktien / Key word(s): Results / QuarterBorussia Dortmund reports preliminary figures for the first quarter (Q1) of the 2026/2027 financial year05-Nov-2026 / 13:02 CE
EQUITY | Nov 05, 2026, 12:06 PM UTC
M
GPGI Expects Q4 Revenue of $630M-$660M
EQUITY | Nov 05, 2026, 12:06 PM UTC
L
Orosur Mining files major holdings notification
Orosur Mining Inc. filed a TR-1 notification of major holdings. The supplied announcement excerpt contains no further details.
EQUITY | Nov 05, 2026, 12:06 PM UTC
M
Korro Bio Reports Third-Quarter Loss per Share
EQUITY | Nov 05, 2026, 12:06 PM UTC
L
BKV Files Form Eight-K Disclosing Investor Presentation
BKV Corp. filed a Form Eight-K with the SEC on November 5, 2026, reporting that it posted an investor presentation on its website.
EQUITY | Nov 05, 2026, 12:06 PM UTC
L
Tripadvisor CEO and CFO to Depart; Interim CFO Named
Matt Goldberg will remain CEO through February 16, 2027, before leaving the role and board. Michael Noonan will resign as CFO effective December 31, 2026, and Kristen Dalton will become interim CFO on January 1, 2027.
EQUITY | Nov 05, 2026, 12:06 PM UTC
M
REGENXBIO Reports Third-Quarter Loss of $40.7 Million
EQUITY | Nov 05, 2026, 12:06 PM UTC
L
BKV Files SEC Operations and Financial Condition Report
BKV Corp. filed an SEC report on November 5, 2026, furnishing its third-quarter 2026 earnings release as an exhibit.
EARNINGS | Nov 05, 2026, 12:06 PM UTC
L
Deputy Economy Minister: Italy is ready to consider changes to its proposed exit tax on rich individuals leaving the country following criticism
Deputy Economy Minister: Italy is ready to consider changes to its proposed exit tax on rich individuals leaving the country following criticism
NEWS | Nov 05, 2026, 12:06 PM UTC
M
ConocoPhillips Sees Fourth-Quarter Production at 2.32M–2.36M BOE/Day
EARNINGS | Nov 05, 2026, 12:06 PM UTC
L
Jefferies Says AstraZeneca Interest in Rhythm Pharmaceuticals Looks Sensible
Jefferies analysts say a potential acquisition would resemble AstraZeneca’s purchase of Alexion on a smaller scale. The Wall Street Journal reported that AstraZeneca made a roughly $10 billion offer for Rhythm Pharmaceut
EQUITY | Nov 05, 2026, 12:06 PM UTC
M
REGENXBIO Reports Third-Quarter 2026 Results
REGENXBIO reported third-quarter 2026 financial results and operational highlights. Its RGX-202 BLA submission for Duchenne muscular dystrophy is on track for Q1 2027, with potential acceleration.
EQUITY | Nov 05, 2026, 12:05 PM UTC
L
Azora Therapeutics Names Five Board Members
Azora Therapeutics' board consists of Matt Davidson, Wendy Young, Aida Habtezion, Thomas Soloway and Paul J. Hastings.
EQUITY | Nov 05, 2026, 12:05 PM UTC
M
Lightspeed Commerce Expects Q3 Revenue of $310M-$320M
EQUITY | Nov 05, 2026, 12:05 PM UTC
M
Unity Expects Q4 Revenue of $683M–$691M
EQUITY | Nov 05, 2026, 12:05 PM UTC
M
Krispy Kreme Reports Third-Quarter Results, Raises Revenue Guidance
Krispy Kreme reported third-quarter 2026 financial results and increased its revenue guidance.
EQUITY | Nov 05, 2026, 12:05 PM UTC
M
N-able Reports Third-Quarter Total ARR of $553.1 Million
EQUITY | Nov 05, 2026, 12:05 PM UTC
M
Rockwell Expects Fiscal 2027 Adjusted EPS of $14.50–$15.50
Rockwell expects fiscal 2027 adjusted EPS of $14.50–$15.50, compared with a FactSet estimate of $14.90.
EARNINGS | Nov 05, 2026, 12:05 PM UTC
L
HSBC Holdings files Form 6-K
HSBC Holdings filed a Form 6-K on November 5.
EQUITY | Nov 05, 2026, 12:05 PM UTC
H
BoE sees real post-tax labour income growth of -0.1% in 2026, -0.6% in 2027, 1.0% in 2028 (July: 0.1% in 2026, 0.5% in 2027, 1.1% in 2028)
BoE sees real post-tax labour income growth of -0.1% in 2026, -0.6% in 2027, 1.0% in 2028 (July: 0.1% in 2026, 0.5% in 2027, 1.1% in 2028)
CENTRAL_BANK | Nov 05, 2026, 12:05 PM UTC
L
Tripadvisor Announces Management Departures and Transition Plan
EQUITY | Nov 05, 2026, 12:05 PM UTC
L
Vistance Networks Announces CEO Succession Plan
Chuck Treadway to Step Down Following Significant Strategic Transformation Board Initiates Search to
EQUITY | Nov 05, 2026, 12:05 PM UTC
M
Ironwood Raises Full-Year 2026 Guidance After Third-Quarter Results
Ironwood said U.S. LINZESS net sales year to date surpassed total 2025 sales, citing sales growth as it raised guidance for the second consecutive quarter.
EQUITY | Nov 05, 2026, 12:05 PM UTC
L
Peptilogics Enrolls First International Patient in Phase 2/3 Trial
The RETAIN trial of zaloganan for prosthetic joint infection has added UK trial sites.
EQUITY | Nov 05, 2026, 12:05 PM UTC
M
Aurora Cannabis Reports Fiscal 2027 Second-Quarter Results
Aurora Cannabis announced results for the quarter ended September 30, 2026. The company also cancelled its scheduled investor call.
EQUITY | Nov 05, 2026, 12:05 PM UTC
L
Versigent CFO to Participate in RBC Capital Markets Conference November 17
EQUITY | Nov 05, 2026, 12:05 PM UTC
M
Bob's Discount Furniture Q3 earnings snapshot
EQUITY | Nov 05, 2026, 12:05 PM UTC
M
Bobs Discount Furniture Sees FY2026 Adjusted EPS of $0.90-$0.96
Bobs Discount Furniture affirmed FY2026 sales guidance of $2.600 billion-$2.625 billion, versus the $2.612 billion estimate. It sees adjusted EPS of $0.90-$0.96.
EARNINGS | Nov 05, 2026, 12:05 PM UTC
L
Bobs Discount Furniture Affirms FY2026 Sales Guidance
The company affirmed FY2026 sales guidance of $2.600 billion to $2.625 billion, versus a $2.612 billion estimate.
EARNINGS | Nov 05, 2026, 12:05 PM UTC
M
Orion Energy Systems Reaffirms FY27 Revenue Guidance at $100M-$102M
The company expects positive adjusted EBITDA and a strong second half, with significant projects in Q3 and Q4.
EQUITY | Nov 05, 2026, 12:05 PM UTC
M
Gold Fields Reports Q3 Production of 605,000 Ounces, Backs Guidance
Gold Fields' attributable gold-equivalent production fell 3% year on year to 605,000 ounces. All-in sustaining costs rose 26% to $1,965 per ounce, while the miner said it remains on track for the upper end of its 2.4 mil
EARNINGS | Nov 05, 2026, 12:05 PM UTC
M
Steven Madden Raises FY2026 EPS and Sales Guidance
Steven Madden raised its FY2026 adjusted EPS guidance to $2.15-$2.20 from $2.05-$2.15 and its sales guidance to $2.825B-$2.850B from $2.799B-$2.850B. The headline cites estimates of $2.19 EPS and $2.879B sales.
EARNINGS | Nov 05, 2026, 12:05 PM UTC
M
Metlen Reports Record Nine-Month Revenue of €6.2 Billion, Up 21%
Metlen Energy & Metals reported nine-month 2026 revenue of €6.2 billion, up 21% year over year, and reaffirmed FY 2026 EBITDA guidance of €1.00–1.15 billion. Its largest H-Class thermal power unit was restored on October
EARNINGS | Nov 05, 2026, 12:05 PM UTC
M
Global Payments Reaffirms 2026 Adjusted EPS View of $13.60-$13.80
EARNINGS | Nov 05, 2026, 12:05 PM UTC
M
DTE Energy Confirms 2026 Operating EPS Guidance of $7.59-$7.73
EARNINGS | Nov 05, 2026, 12:05 PM UTC
M
ANI Pharmaceuticals raises 2026 adjusted EPS view to $9.37–$9.71
EARNINGS | Nov 05, 2026, 12:05 PM UTC
M
Kontoor Brands Expects Full-Year Adjusted EPS of $5.40
EARNINGS | Nov 05, 2026, 12:05 PM UTC
M
Cardinal Health reports first-quarter EPS of $2.38
EARNINGS | Nov 05, 2026, 12:05 PM UTC
M
Air Products Reports Higher Q4 Profit and Revenue, Sees Higher FY27 Adjusted EPS
Air Products reported higher fourth-quarter profit and revenue and forecast higher adjusted earnings for fiscal 2027.
EQUITY | Nov 05, 2026, 12:05 PM UTC
H
BoE sees private-sector regular wage growth of 3.2% yy in Q4 2026, 3.5% in @4 2027, 3.4% in Q4 2028 (July: 3.0% in Q4 2026, 3.1% in Q4 2027, 3.1% in Q4 2028)
BoE sees private-sector regular wage growth of 3.2% yy in Q4 2026, 3.5% in @4 2027, 3.4% in Q4 2028 (July: 3.0% in Q4 2026, 3.1% in Q4 2027, 3.1% in Q4 2028)
CENTRAL_BANK | Nov 05, 2026, 12:05 PM UTC
L
Wendy’s Committee Says Proposal Undervalues Long-Term Prospects
Wendy’s committee unanimously concluded that the proposal substantially undervalues the company’s standalone prospects and long-term earnings potential.
EQUITY | Nov 05, 2026, 12:05 PM UTC
L
Vistance Networks CEO Chuck Treadway to Step Down February 1, 2027
Chuck Treadway will also leave his board seat on February 1, 2027. The board has begun a search for his successor.
EQUITY | Nov 05, 2026, 12:05 PM UTC
M
Global Payments Maintains 2026 Adjusted Revenue Growth Outlook at 4%-5%
Global Payments still expects 2026 constant-currency adjusted net revenue growth of 4%-5%.
EARNINGS | Nov 05, 2026, 12:05 PM UTC
M
GPGI Sees 4Q Adjusted EBITDA of $178M-$208M
EARNINGS | Nov 05, 2026, 12:05 PM UTC
M
BCE Reports Q3 Adjusted Earnings of 0.74
BCE reported Q3 adjusted earnings of 0.74. Its headline also says adjusted earnings declined and operating revenue increased.
EQUITY | Nov 05, 2026, 12:05 PM UTC
M
Iron Mountain Sees 2026 Revenue of $7.95B-$8.02B
EARNINGS | Nov 05, 2026, 12:05 PM UTC
M
DTE Energy Beats Q3 EPS by $0.12, Reaffirms FY26 Guidance
DTE Energy reported Q3 earnings of $2.25 per share, excluding non-recurring items, $0.12 above estimates. It reaffirmed FY26 EPS guidance and announced a unit sale.
EARNINGS | Nov 05, 2026, 12:05 PM UTC
L
Dream Finders Says Beazer Note Exchange Drew 99.22% Early Tenders
As of the Nov. 4 early participation deadline, holders had tendered 99.22% of Beazer's 7.500% senior notes.
EQUITY | Nov 05, 2026, 12:05 PM UTC
L
Precision BioSciences DSMB Clears Additional PBGENE-DMD Dosing
The independent DSMB found no safety concerns after reviewing the first treated patient in the Phase 1/2 study.
EQUITY | Nov 05, 2026, 12:05 PM UTC
H
BoE adverse scenario shows CPI peaking at 6.2% in Q3 2027
BoE adverse scenario shows CPI peaking at 6.2% in Q3 2027
CENTRAL_BANK | Nov 05, 2026, 12:05 PM UTC
M
Horizon Quantum Signs Non-Binding Letter of Intent to Acquire Entropica Labs
Horizon Quantum Holdings said it signed a non-binding letter of intent to acquire Entropica Labs.
EQUITY | Nov 05, 2026, 12:05 PM UTC
L
1stDibs Names Bradford Shellhammer CEO, Rosenblatt Executive Chair
Bradford Shellhammer will become CEO effective Jan. 1, 2027, while Rosenblatt will become executive chair. Shellhammer is currently chief product and marketing officer.
EQUITY | Nov 05, 2026, 12:05 PM UTC
L
Vistance Networks Announces CEO Succession Plan
Chuck Treadway will step down as president and CEO and leave the company’s board on February…
EQUITY | Nov 05, 2026, 12:05 PM UTC
M
N-able reports third-quarter loss of $4.37 million
EQUITY | Nov 05, 2026, 12:05 PM UTC
H
BoE sees an unemployment rate of 4.8% in 2026, 4.9% in 2027, 5.1% in 2028 (July: 5.0% in 2026, 5.3% in 2027, 5.2% in 2028)
BoE sees an unemployment rate of 4.8% in 2026, 4.9% in 2027, 5.1% in 2028 (July: 5.0% in 2026, 5.3% in 2027, 5.2% in 2028)
CENTRAL_BANK | Nov 05, 2026, 12:05 PM UTC
L
Ironwood Pharmaceuticals Reports Third-Quarter Adjusted EPS
EARNINGS | Nov 05, 2026, 12:05 PM UTC
M
Iron Mountain Sees Fourth-Quarter Revenue at About $2.03B
EARNINGS | Nov 05, 2026, 12:05 PM UTC
M
Cardinal Health Reports Fiscal Q1 2027 Results, Raises Outlook
EQUITY | Nov 05, 2026, 12:05 PM UTC
L
Dunham Wins Asset Management STAR Award and Four Luminaries Finalist Honors
Dunham received a Boutique Winner honor from IMEA, FT Live, Ignites and FundFire for advisor-focused content.
EQUITY | Nov 05, 2026, 12:05 PM UTC
L
Nanoscope Therapeutics Appoints Damon Daulerio Executive Director of Regulatory Affairs
EQUITY | Nov 05, 2026, 12:05 PM UTC
M
Madison Air Solutions Reports Third-Quarter Sales of $1.13B
Madison Air Solutions reported third-quarter sales of $1.13 billion.
EARNINGS | Nov 05, 2026, 12:05 PM UTC
L
Ironwood Pharmaceuticals Reports Third-Quarter Net Income of $59.8 Million
EARNINGS | Nov 05, 2026, 12:05 PM UTC
L
JETSET Pilates Plans First Virginia Studio in Tysons
Multi-unit developer Vertex Fitness Group plans to open three Virginia studios over three months.
EQUITY | Nov 05, 2026, 12:05 PM UTC
L
Bernstein Says Burberry Sales Expectations Seem Reasonable
Bernstein analysts say Burberry’s consensus expectations appear reasonable amid weakened luxury demand through the summer. The company is due to report fiscal first-half results on Nov. 12.
EQUITY | Nov 05, 2026, 12:05 PM UTC
L
Vertex Expands European Operations With Quartz Project Services Acquisition
MNA | Nov 05, 2026, 12:05 PM UTC
H
BoE: Market rates imply bank rate at 3.9% in Q4 2026, 4.9% in Q4 2027, 4.9% in Q4 2028, 4.7% in Q4 2029
BoE: Market rates imply bank rate at 3.9% in Q4 2026, 4.9% in Q4 2027, 4.9% in Q4 2028, 4.7% in Q4 2029
CENTRAL_BANK | Nov 05, 2026, 12:05 PM UTC
M
Acacia Research Reports Q3 2026 Results
Revenue was $54.4 million, down 8% from the prior-year quarter; GAAP net loss was $5.6 million.
EQUITY | Nov 05, 2026, 12:05 PM UTC
M
Shutterstock Reports Third-Quarter 2026 Financial Results
EQUITY | Nov 05, 2026, 12:05 PM UTC
L
Iron Mountain Expects Fiscal 2026 Adjusted FFO of $5.94–$6
Iron Mountain expects fiscal 2026 adjusted FFO of $5.94 to $6, versus a FactSet estimate of $5.92.
EARNINGS | Nov 05, 2026, 12:05 PM UTC
L
Azora Therapeutics Establishes Board of Directors
Azora Therapeutics established a board of directors with drug development and inflammatory bowel disease expertise.
EQUITY | Nov 05, 2026, 12:04 PM UTC
L
Kayak Therapeutics Announces IND Clearance for KT-300
The company said KT-300 is an oral small-molecule TRIM7 inhibitor designed to target RAS-driven cancers.
EQUITY | Nov 05, 2026, 12:04 PM UTC
M
Illumin Reports Q3 2026 Revenue of $42.7 Million, Up 12%
Illumin said third-quarter revenue rose 12% year over year to $42.7 million. Exchange revenue grew 24% year over year.
EQUITY | Nov 05, 2026, 12:04 PM UTC
M
Global Payments expects 2026 adjusted EPS of $13.60–$13.80
The company’s 2026 adjusted EPS range compares with a FactSet estimate of $13.64.
EARNINGS | Nov 05, 2026, 12:04 PM UTC
L
Aquestive Therapeutics to Present Data at 2026 ACAAI Annual Meeting
Aquestive Therapeutics said it will present data at the 2026 ACAAI Annual Meeting.
EQUITY | Nov 05, 2026, 12:04 PM UTC
M
Lifetime Brands Reports Third-Quarter 2026 Results
Lifetime Brands also declared a regular quarterly dividend and authorized a $20 million share repurchase program.
EQUITY | Nov 05, 2026, 12:04 PM UTC
M
GPGI Sees Fourth-Quarter Sales of $630M-$660M
EARNINGS | Nov 05, 2026, 12:04 PM UTC
M
Bentley Systems Reports Q3 Revenue of $421.5M
Bentley Systems reported Q3 revenue of $421.5 million, versus a FactSet estimate of $420.7 million.
EQUITY | Nov 05, 2026, 12:04 PM UTC
L
Insight Molecular Diagnostics Sets Third-Quarter Results Release for Nov. 16
Insight Molecular Diagnostics plans to release its third-quarter results on November 16, 2026.
EQUITY | Nov 05, 2026, 12:04 PM UTC
L
Global Payments Reaffirms 2026 Full-Year Outlook and Capital-Return Plan
EARNINGS | Nov 05, 2026, 12:04 PM UTC
M
Ingredion Q3 Adjusted Earnings and Sales Fall
Ingredion reported lower Q3 adjusted earnings and sales. Shares were down before the bell.
EQUITY | Nov 05, 2026, 12:04 PM UTC
M
Cartesian Therapeutics Reports Third-Quarter 2026 Results and Business Update
The company said its Phase 3 AURORA trial of Descartes-08 in myasthenia gravis is advancing toward a data readout; the body text is truncated.
EQUITY | Nov 05, 2026, 12:04 PM UTC
L
TD Downgrades Linamar to Hold from Buy
EQUITY | Nov 05, 2026, 12:04 PM UTC
L
Beamr Expects Approximately 50% Revenue Growth in 2026
Beamr CEO Sharon Carmel discussed the company's commercial progress and physical AI opportunity in an interview.
EARNINGS | Nov 05, 2026, 12:04 PM UTC
M
Entrada Therapeutics Reports Third-Quarter 2026 Financial Results
Entrada Therapeutics said all ELEVATE-44-201 Cohort 1 participants completed open-label dosing; data are expected to
EQUITY | Nov 05, 2026, 12:04 PM UTC
L
Charming Medical Receives Nasdaq Delisting Determination Notice
EQUITY | Nov 05, 2026, 12:04 PM UTC
M
Warby Parker Sees FY Revenue of $966M–$976M
EARNINGS | Nov 05, 2026, 12:04 PM UTC
L
HydroGraph to Showcase Graphene-Carbon Black Hybrid at AMI Plastics World Expo
HydroGraph Clean Power says it will showcase a graphene-carbon black hybrid for conductive compounds at the AMI Plastics World Expo.
EQUITY | Nov 05, 2026, 12:04 PM UTC
L
Lithium Ionic Files Defence and Counterclaims in Emerita Litigation
Lithium Ionic Corp. filed a statement of defence, crossclaim, counterclaim and third-party claim in litigation involving Emerita Resources.
REGULATION | Nov 05, 2026, 12:04 PM UTC
H
BoE's Taylor, Dhingra: Rate hike represents insurance against worse inflation outcomes
BoE's Taylor, Dhingra: Rate hike represents insurance against worse inflation outcomes
CENTRAL_BANK | Nov 05, 2026, 12:04 PM UTC
M
Six Flags Says Georgia Accident Will Cut Quarterly EBITDA
Six Flags forecast current-quarter same-park EBITDA below the year-earlier $167 million after a fatal rollercoaster accident in Georgia in October.
EARNINGS | Nov 05, 2026, 12:04 PM UTC
M
Pyxis Oncology Reports Third-Quarter 2026 Financial Results
The company also highlighted progress toward pivotal development of micvotabart pelidotin (MICVO).
EQUITY | Nov 05, 2026, 12:04 PM UTC
L
Electrolit Launches Holiday Retail Campaign Featuring Freestyle Skier Janelle Yip
Electrolit athlete and professional freestyle skier Janelle Yip stars in the seasonal campaign.
EQUITY | Nov 05, 2026, 12:04 PM UTC
M
GPGI Reports Third-Quarter 2026 Results
GPGI said its results were in line with expectations, citing strength at CompoSecure and improving demand at Hu.
EQUITY | Nov 05, 2026, 12:04 PM UTC
M
Unity Reports Third-Quarter 2026 Financial Results
EQUITY | Nov 05, 2026, 12:04 PM UTC
M
Middleby Reports Q3 Results, Raises Full-Year Guidance
Middleby said Q3 2026 results exceeded the high end of its guidance range for net sales and raised full-year guidance.
EQUITY | Nov 05, 2026, 12:04 PM UTC
M
Keel Infrastructure Reports Third-Quarter 2026 Results
Keel Infrastructure reported third-quarter 2026 results and cited progress with permitting, commercialization and lease negotiations across three n.
EQUITY | Nov 05, 2026, 12:04 PM UTC
M
BKV Reports Third-Quarter 2026 Results
EQUITY | Nov 05, 2026, 12:04 PM UTC
L
Genprex Presents Reqorsa Gene Therapy Data on TUSC2 and Aging Biology
Genprex says a whole-blood analysis from clinical trial patients links TUSC2 to cellular repair and maintenance programs associated with aging biology. The supplied body is truncated.
EQUITY | Nov 05, 2026, 12:04 PM UTC
L
EyePoint Schedules Third-Quarter 2026 Results for November 12
EyePoint said it will report its third-quarter 2026 financial results on November 12, 2026.
EQUITY | Nov 05, 2026, 12:04 PM UTC
L
Precision BioSciences Reports Positive Safety Review for PBGENE-DMD Trial
The first patient completed the post-treatment observation period with no reported safety issues, supporting additional dosing in the Phase 1/2 FUNCTION-DMD study.
EQUITY | Nov 05, 2026, 12:04 PM UTC
L
Precision BioSciences Reports PBGENE-HBV Data and Phase 2 Plans
The company says its Phase 1 ELIMINATE-B study was successful and the PBGENE-HBV program is advancing to Phase 2. The supplied text also refers to data demonstrating cccDNA elimination and potential to drive a viral cure
EQUITY | Nov 05, 2026, 12:04 PM UTC
L
Madison Air Solutions Reports Third-Quarter Adjusted EPS
EARNINGS | Nov 05, 2026, 12:04 PM UTC
L
Copper Road Files Permits for 6,000-Metre Ben Nevis Drilling Program
Copper Road Resources filed permit applications for a maiden 6,000-metre drilling program at the Ben Nevis Volcanic Complex.
EQUITY | Nov 05, 2026, 12:04 PM UTC
M
Papa Johns Reports Third-Quarter 2026 Results, Updates Outlook
Papa Johns updated its fiscal 2026 outlook and introduced Unbox Better, a brand and franchise-system initiative.
EQUITY | Nov 05, 2026, 12:04 PM UTC
L
Alkermes Showcases Psychiatry and Sleep Portfolio Research
Alkermes presented research at the Neuroscience Education Institute Fall Congress, including a real-world assessment of acute-care impact after initiating LYBALVI.
EQUITY | Nov 05, 2026, 12:04 PM UTC
M
GPGI Reports Third-Quarter Adjusted EBITDA of $146.3M
EARNINGS | Nov 05, 2026, 12:04 PM UTC
M
Viatris Raises 2026 Adjusted EBITDA View to $4.45B-$4.55B
EARNINGS | Nov 05, 2026, 12:04 PM UTC
L
Nathan’s Famous files Form 15-12G
Nathan’s Famous filed Form 15-12G on November 5; the filing year is incomplete in the source.
EQUITY | Nov 05, 2026, 12:04 PM UTC
L
Ballard Fuel Cell Engine Debuts in Solaris Hydrogen Bus Production
Ballard’s FCmove®-SC fuel cell engine makes its series-production debut in the next-generation Solaris Urbino 12 hydrogen bus.
EQUITY | Nov 05, 2026, 12:04 PM UTC
M
Nexstar Reports Record Quarterly Revenue of $2.1 Billion
Nexstar said Q3 net income was $250 million and adjusted EBITDA was $756 million.
EQUITY | Nov 05, 2026, 12:04 PM UTC